migraine

Migraine market to reach $16.4 billion in 7MM by 2033, forecasts GlobalData

Read more

Akums launches Lasmiditan Tablet for migraine management

Read more

ZIM Labs gets marketing authorisation for Rizatriptan orally dissolving film in Portugal

Read more

Ajanta Pharma receives US FDA approval for migraine drug

Read more

Jubilant Life Sciences gets US FDA nod

Read more

New blood biomarker for migraine identified

Read more

Novartis in global partnership with Amgen

Read more